CHCM
PFE icon

Columbus Hill Capital Management’s Pfizer PFE Stock Holding History

Columbus Hill Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-427,262
Closed -$14.5M – 62
2017
Q3 		$14.5M Sell
427,262
-24,386
-5% -$784K 1.03% 37
2017
Q2 		$14.4M Sell
451,648
-12,490
-3% -$394K 1.45% 26
2017
Q1 		$15.1M Buy
464,138
+169,018
+57% +$5.33M 0.75% 27
2016
Q4 		$9.09M Buy
+295,120
New +$9.01M 1.03% 29

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Columbus Hill Capital Management's PFE Position: Q4 2017 in Review

Columbus Hill Capital Management sold out of Pfizer (PFE) in Q4 2017, closing a stake of 427,262 shares — an estimated $14.5M sold.

Columbus Hill Capital Management first reported a position in PFE in Q4 2016 and held it in 4 quarters. The position peaked at $15.1M in Q1 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Columbus Hill Capital Management reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Columbus Hill Capital Management sold 427,262 Pfizer shares in Q4 2017, an estimated $14.5M.
  • Columbus Hill Capital Management first reported a position in Pfizer in Q4 2016 and held it in 4 quarters.
  • Columbus Hill Capital Management's Pfizer position peaked at $15.1M in Q1 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Columbus Hill Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.